某院肿瘤科临床药师干预前后医嘱合理性评价  

Rationality Evaluation of Medical Order in Oncology Department of a Hospital Before and After the Intervention of Clinical Pharmacist

作　　者：陈国梅[1] 杨忠慧[1] 胡旻昊 

机构地区：[1]苏州大学附属太仓医院药剂科,江苏太仓215400

出　　处：《中国药师》2017年第4期692-694,共3页China Pharmacist

基　　金：苏州市2014年度科技发展计划项目(编号:SYSD2014153)

摘　　要：目的:评价某院肿瘤科医嘱的合理性,分析临床药师干预的效果。方法:选取该院2013年1~6月肿瘤科出院病历180份作为干预前组,2014年1~6月肿瘤科出院病历180份作为干预后组,调查比较干预前后药物选择、用药途径、用法用量等医嘱的合理性。结果:干预前后不合理率分别为41.11%和8.33%,差异有统计学意义(P<0.05)。不合理用药主要为适应证不适宜、用法用量不适宜、更换药物不适宜、联合用药不适宜、辅助用药不合理等。结论:通过临床药师的干预,可以显著减少肿瘤科不合理用药现象,提高医院合理用药的水平。Objective： To evaluate the rationality of medical order in oncology department of our hospital and analyze the intervention effect of clinical pharmacist. Methods： Totally 180 medical orders in oncology department of our hospital from January to June in 2013 were selected as the pre-intervention group, and those with the same number from January to June in 2014 were selected as the post-intervention group. The rationality of medical orders including drug selection, administration routes, usage and dosage was investigated and compared between the groups. Results： The unreasonable rate was 41.11% before the intervention and 8.33% after the intervention with statistically significant difference（ P 〈0.05 ）. The irrational drug use included inappropriate indications,usage and dosage, improper drug replacement and combination, and inappropriate adjuvant drug use. Conclusion： Irrational drug use in oncology department can be significantly reduced and the level of rational drug use can be improved through the intervention of clinical pharmacist.

关 键 词：临床药师 肿瘤科 医嘱 干预 合理用药 

分 类 号：R969.3[医药卫生—药理学]